Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
TAO Synergies Inc
TAOX
Financial Services
Cryptocurrency
TAO Synergies Inc., formerly Synaptogenix, Inc., is a pure-play company focused on the convergence between cryptocurrency and artificial intelligence (AI). The Company's differentiated cryptocurrency treasury strategy is centered exclusively on the acquisition of TAO, the native cryptocurrency of Bittensor, a decentralized blockchain network for machine learning and AI.
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:TAOX)
New Post
View:
Posts & Comments
Threaded Posts
(224)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Jun 09, 2025 9:50am
Using technical analysis for this stock.
This stock is signalling a big upswing for shareholders this morning and
(10)
•••
MikeTester
X
Post by
MikeTester
on Aug 02, 2024 6:43am
Synaptogenix, Inc. (NASDAQ:SNPX): Advancing Neurological Tre
https://beyondspx.com/2024/08/01/synaptogenix-inc-nasdaqsnpx-advancing-neurological-treatments-with-bryostatin-1/
Fineqia's Yield-Bearing Bitcoin ETP Garners $15.1 Mln; Total Co. AUM Reaches $41 Mln
posted Jul 09, 2025 9:00am by
Fineqia International Inc.
-
|
Unlike traditional passive Bitcoin products, YBTC reinvests DeFi-generated rewards back into Bitcoin over time. This structure offers the potential to grow one's Bitcoin holdings automatically, within a regulated, transparent, and exchange-listed format. ...read more
(0)
•••
PressRelease
X
Post by
PressRelease
on Jul 19, 2023 9:00am
New Press Release - Synaptogenix and Cleveland Clinic to Submit Investigational New Drug (IND) Application to FDA for Clinical Trial of Bryostatin-1 in Multiple Sclerosis
Study will evaluate drug's potential neuro-restorative mechanism(s) of action for improving synaptic health and cognitive function in MS patientsNEW YORK, July 19, 2023 /PRNewswire/ -- Synaptogenix, Inc. (Nasdaq: SNPX) ("Synaptogenix" or the "Company"), an emerging biopharmaceutical company...
read article.
(156)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 14, 2023 2:18pm
SNPX ...... big bid just showed up
Smoke & f'king mirrors Whack it ; )
(156)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 14, 2023 2:14pm
SNPX ....just saw this ....it's still alive
Kind of .....Big P & D yesterday...total joke All the Chasers got slaughtered...as usual
(156)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 13, 2023 3:35pm
SNPX.....Don't tell me the last 1/2 hr heroics
is starting Better pump up the volume
(156)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 13, 2023 12:48pm
SNPX .... Now for the rally from sub $1.00....
heading back up to fill thhat gap above $1.25 I'm in sub $1.00 GLT me
(156)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 13, 2023 12:20pm
SNPX ....turned out to be a "spearcatching " game
What a f'king game
(156)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 13, 2023 10:37am
SNPX....Runner on watch list
Trading at $1.55 P.O last year at $7......I'd say people want their money back Needs to break thru $1.80 with volume
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Eshbal Signs LOI to Acquire Gluten Free Nation a Company Specializing in Gluten-Free Baked Goods